AIMI 8-K 2026-01-12

AIM ImmunoTech Inc. (AIMI) 8-K dated 2026-01-12 — accession 0001493152-26-001898. This URL is the filing, not the AIMI hub.

AIM ImmunoTech Inc. (AIMI) is a biotechnology company listed on US.

AIM ImmunoTech Inc. filed a 8-K on 2026-01-12. Accession 0001493152-26-001898.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AIMI revenue for 2024-12-31 was $170.0K. Net income was -$17.3M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. AIMI currently screens at market cap $878.9K.

Not investment advice. The AIMI SEC hub lists recent forms. The stock page is the research view.